Aspirin in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome: An Old, Low-Cost Therapy With a Strong Rationale.

Coppola, Silvia; Chiumello, Davide

Coppola, Silvia; Chiumello, Davide.

Coppola S; From the Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.
Chiumello D; From the Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.

Anesth Analg ; 132(4): 927-929, 2021 04 01.

Article in English | MEDLINE | ID: covidwho-1136267

Subject(s)

COVID-19; Respiratory Distress Syndrome; Aspirin/adverse effects; Hospital Mortality; Humans; Intensive Care Units; Respiration, Artificial; Respiratory Distress Syndrome/diagnosis; Respiratory Distress Syndrome/therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Anesth Analg Year: 2021 Document Type: Article Affiliation country: ANE.0000000000005408

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google